{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:17:10Z","timestamp":1775607430550,"version":"3.50.1"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Diencephalic tumors tend to be low grade tumors located near several critical structures, including the optic nerves, optic chiasm, pituitary, hypothalamus, Circle of Willis, and hippocampi. In children, damage to these structures can impact physical and cognitive development over time. Thus, the goal of radiotherapy is to maximize long term survival while minimizing late effects, including endocrine disruption leading to precocious puberty, height loss, hypogonadotropic hypogonadism, and primary amenorrhea; visual disruption including blindness; and vascular damage resulting in cerebral vasculopathy. Compared to photon therapy, proton therapy offers the potential to decrease unnecessary dose to these critical structures while maintaining adequate dose to the tumor. In this article, we review the acute and chronic toxicities associated with radiation for pediatric diencephalic tumors, focusing on the use of proton therapy to minimize treatment-related morbidity. Emerging strategies to further reduce radiation dose to critical structures will also be considered.<\/jats:p>","DOI":"10.3389\/fonc.2023.1123082","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T06:00:22Z","timestamp":1683266422000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Proton therapy for pediatric diencephalic tumors"],"prefix":"10.3389","volume":"13","author":[{"given":"Adam J.","family":"Grippin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"McGovern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-011-1395-z","article-title":"Diencephalic tumors in children: a 30-year experience of a single institution","volume":"27","author":"Yazici","year":"2011","journal-title":"Childs Nerv Syst"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(02)02799-2","article-title":"Craniopharyngioma: The St. Jude's children\u2019s research hospital experience 1984-2001","volume":"53","author":"Merchant","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.14791\/btrt.2022.0003","article-title":"Recent updates on radiation therapy for pediatric optic pathway glioma","volume":"10","author":"Kim","year":"2022","journal-title":"Brain Tumor Res Treat"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(90)90396-2","article-title":"Pineal and CNS germ cell tumors: Royal Marsden hospital experience 1962-1987","volume":"18","author":"Dearnaley","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1023\/A:1005732105727","article-title":"Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy","volume":"32","author":"Robertson","year":"1997","journal-title":"J Neurooncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11060-013-1306-0","article-title":"Multimodality therapy for CNS mixed malignant germ cell tumors (MMGCT): results of a phase II multi-institutional study","volume":"118","author":"Robertson","year":"2014","journal-title":"J Neurooncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.9.7819","article-title":"Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria","volume":"86","author":"Kreutzer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.3171\/foc.2007.23.3.7","article-title":"Transsphenoidal surgery for cushing\u2019s disease: a review of success rates, remission predictors, management of failed surgery, and nelson\u2019s syndrome","volume":"23","author":"Kelly","year":"2007","journal-title":"Neurosurg Focus"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.12.008","article-title":"Phase II study of carboplatin in children with progressive low-grade gliomas","volume":"20","author":"Gururangan","year":"2002","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000267","article-title":"Late effects after radiotherapy for childhood low-grade glioma","volume":"41","author":"Williams","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e26997","DOI":"10.1002\/pbc.26997","article-title":"Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors","volume":"65","author":"Mokhtech","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.01.078","article-title":"Outcomes following proton therapy for pediatric low-grade glioma","volume":"104","author":"Indelicato","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3171\/2010.5.JNS091635","article-title":"Gamma knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes","volume":"114","author":"Sheehan","year":"2011","journal-title":"J Neurosurg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.addr.2016.11.006","article-title":"Proton therapy - present and future","volume":"109","author":"Mohan","year":"2017","journal-title":"Adv Drug Delivery Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25494","article-title":"Proton therapy for pediatric and adolescent esthesioneuroblastoma","volume":"62","author":"Lucas","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyy454","article-title":"The promise of proton therapy for central nervous system malignancies","volume":"84","author":"Vogel","year":"2019","journal-title":"Neurosurgery"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/nop\/npz033","article-title":"Neuro-oncology practice clinical debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma","volume":"7","author":"Cooney","year":"2020","journal-title":"Neurooncol Pract"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199903)45:3<393::AID-ANA17>3.0.CO;2-B","article-title":"Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma","volume":"45","author":"Grill","year":"1999","journal-title":"Ann Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29907","article-title":"Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study","volume":"122","author":"Krishnatry","year":"2016","journal-title":"Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noq178","article-title":"Survival and long-term health and cognitive outcomes after low-grade glioma","volume":"13","author":"Armstrong","year":"2011","journal-title":"Neuro Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/adc.79.4.334","article-title":"Long-term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era","volume":"79","author":"Cappelli","year":"1998","journal-title":"Arch Dis Child"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.2738","article-title":"Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits","volume":"27","author":"Merchant","year":"2009","journal-title":"J Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.9494","article-title":"Phase II trial of conformal radiation therapy for pediatric low-grade glioma","volume":"27","author":"Merchant","year":"2009","journal-title":"J Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11119","article-title":"Survival and functional outcome of children with hypothalamic\/chiasmatic tumors","volume":"97","author":"Fouladi","year":"2003","journal-title":"Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.07.023","article-title":"Radiation therapy for optic pathway and hypothalamic low-grade gliomas in children","volume":"99","author":"Tsang","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00359-3","article-title":"Childhood optic chiasm gliomas: radiographic response following radiotherapy and long-term clinical outcome","volume":"39","author":"Tao","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/BF02072067","article-title":"Growth and endocrine disorders in optic glioma","volume":"149","author":"Brauner","year":"1990","journal-title":"Eur J Pediatr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1046\/j.1365-2265.1997.2211032.x","article-title":"Endocrine outcome in long-term survivors of low-grade hypothalamic\/chiasmatic glioma","volume":"47","author":"Collet-Solberg","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.04.053","article-title":"Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas","volume":"89","author":"Greenberger","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-002-0874-2","article-title":"Conformal proton radiation therapy for pediatric low-grade astrocytomas","volume":"178","author":"Hug","year":"2002","journal-title":"Strahlenther Onkol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(99)00337-5","article-title":"Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique","volume":"45","author":"Fuss","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000120866","article-title":"Surgery, radiation, and combination therapy in the treatment of childhood craniopharyngioma\u2013a 20-year experience","author":"Scott","year":"1994","journal-title":"Pediatr Neurosurg"},{"key":"B33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s003810050108","article-title":"Long-term results of treatment for craniopharyngioma in children","volume":"13","author":"Villani","year":"1997","journal-title":"Childs Nerv Syst"},{"key":"B34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0360-3016(89)90005-9","article-title":"A comparison of the roles of surgery and radiation therapy in the management of craniopharyngiomas","volume":"16","author":"Wen","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.15919","article-title":"Craniopharyngiomas invading the ventricular system: A systematic review","volume":"42","author":"Palmisciano","year":"2022","journal-title":"Anticancer Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11060-021-03908-2","article-title":"Radiotherapy alone for pediatric patients with craniopharyngioma","volume":"156","author":"Young","year":"2022","journal-title":"J Neurooncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-012-1926-2","article-title":"A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma","volume":"29","author":"Clark","year":"2013","journal-title":"Childs Nerv Syst"},{"key":"B38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3171\/2012.7.PEDS11436","article-title":"Treatment-related morbidity and the management of pediatric craniopharyngioma: a systematic review","volume":"10","author":"Clark","year":"2012","journal-title":"J Neurosurg Pediatr"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-019-04294-x","article-title":"Sixty years single institutional experience with pediatric craniopharyngioma: between the past and the future","volume":"36","author":"Fouda","year":"2020","journal-title":"Childs Nerv Syst"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2020.11.PEDS20803","article-title":"Comparison of multimodal surgical and radiation treatment methods for pediatric craniopharyngioma: long-term analysis of progression-free survival and morbidity","author":"Ravindra","year":"2021","journal-title":"J Neurosurg Pediatr"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22884","article-title":"Long-term clinical outcomes following treatment of childhood craniopharyngioma","volume":"56","author":"Winkfield","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25889","article-title":"A cross-sectional cohort study of cerebrovascular disease and late effects after radiation therapy for craniopharyngioma","volume":"63","author":"Lo","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.05.051","article-title":"Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity","volume":"90","author":"Bishop","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.02.045","article-title":"Proton radiation therapy for pediatric craniopharyngioma","volume":"110","author":"Jimenez","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26654","article-title":"Clinical outcomes following proton therapy for children with central nervous system tumors referred overseas","volume":"64","author":"Indelicato","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.03.027","article-title":"Risk of radiation vasculopathy and stroke in pediatric patients treated with proton therapy for brain and skull base tumors","volume":"101","author":"Hall","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2021.1.PEDS20819","article-title":"Predictors of progression in radiation-induced versus nonradiation-induced pediatric meningiomas: a large single-institution surgical experience","author":"Fouda","year":"2021","journal-title":"J Neurosurg Pediatr"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/nop\/npaa061","article-title":"Systematic review of the incidence and risk factors for cerebral vasculopathy and stroke after cranial proton and photon radiation for childhood brain tumors","volume":"8","author":"Bavle","year":"2021","journal-title":"Neurooncol Pract"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.10.015","article-title":"Cerebrovascular diseases in childhood cancer survivors: Role of the radiation dose to Willis circle arteries","volume":"97","author":"El-Fayech","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2019.08.002","article-title":"Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in paediatric craniopharyngioma","volume":"142","author":"Toussaint","year":"2020","journal-title":"Radiother Oncol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.11.027","article-title":"Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas","volume":"82","author":"Boehling","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.01.005","article-title":"On the benefits and risks of proton therapy in pediatric craniopharyngioma","volume":"82","author":"Beltran","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.10.020","article-title":"Intracranial germ cell tumors in adolescents and young adults: A 40-year multi-institutional review of outcomes","volume":"106","author":"Lo","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz139","article-title":"Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT consortium","volume":"21","author":"Takami","year":"2019","journal-title":"Neuro Oncol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/neuonc\/noaa199","article-title":"So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma","volume":"23","author":"Kanamori","year":"2021","journal-title":"Neuro Oncol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-020-03642-1","article-title":"Long term toxicity of intracranial germ cell tumor treatment in adolescents and young adults","volume":"149","author":"Wong","year":"2020","journal-title":"J Neurooncol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-015-2029-1","article-title":"Outcomes of children with central nervous system germinoma treated with multi-agent chemotherapy followed by reduced radiation","volume":"127","author":"Cheng","year":"2016","journal-title":"J Neurooncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-009-0033-z","article-title":"Challenges in management of patients with intracranial germ cell tumor and diabetes insipidus treated with cisplatin and\/or ifosfamide based chemotherapy","volume":"97","author":"Afzal","year":"2010","journal-title":"J Neurooncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not019","article-title":"SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease","volume":"15","author":"Calaminus","year":"2013","journal-title":"Neuro Oncol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11060-013-1197-0","article-title":"Late causes of death in children treated for CNS malignancies","volume":"115","author":"Perkins","year":"2013","journal-title":"J Neurooncol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001820","article-title":"Outcomes of local radiation and intensified combined intrathecal methotrexate and high-dose chemotherapy for intracranial germ cell tumors","volume":"42","author":"Yamasaki","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab252","article-title":"EANO, SNO and euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults","volume":"24","author":"Frappaz","year":"2022","journal-title":"Neuro Oncol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.5132","article-title":"Phase II trial assessing the ability of neoadjuvant chemotherapy with or without second-look surgery to eliminate measurable disease for nongerminomatous germ cell tumors: A children\u2019s oncology group study","volume":"33","author":"Goldman","year":"2015","journal-title":"J Clin Oncol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00701","article-title":"Phase II trial of response-based radiation therapy for patients with localized CNS nongerminomatous germ cell tumors: A children\u2019s oncology group study","volume":"37","author":"Fangusaro","year":"2019","journal-title":"J Clin Oncol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox122","article-title":"Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial","volume":"19","author":"Calaminus","year":"2017","journal-title":"Neuro Oncol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2020.1052","article-title":"Long-term outcomes and sequelae analysis of intracranial germinoma: Need to reduce the extended-field radiotherapy volume and dose to minimize late sequelae","volume":"53","author":"Lee","year":"2021","journal-title":"Cancer Res Treat"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou311","article-title":"Long-term outcomes and late effects for childhood and young adulthood intracranial germinomas","volume":"17","author":"Acharya","year":"2015","journal-title":"Neuro Oncol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13014-015-0441-5","article-title":"Differential dosimetric benefit of proton beam therapy over intensity modulated radiotherapy for a variety of targets in patients with intracranial germ cell tumors","volume":"10","author":"Park","year":"2015","journal-title":"Radiat Oncol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e29697","DOI":"10.1002\/pbc.29697","article-title":"Photon versus proton whole ventricular radiotherapy for non-germinomatous germ cell tumors: A report from the children\u2019s oncology group","volume":"69","author":"Mak","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2016.204","article-title":"Neurocognitive and psychological functioning of children with an intracranial germ cell tumor","volume":"49","author":"Park","year":"2017","journal-title":"Cancer Res Treat"},{"key":"B71","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1186\/s12885-020-07484-y","article-title":"Treatment outcome and long-term follow-up of central nervous system germ cell tumor using upfront chemotherapy with subsequent photon or proton radiation therapy: a single tertiary center experience of 127 patients","volume":"20","author":"Hong","year":"2020","journal-title":"BMC Cancer"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01219-x","article-title":"Endocrine disorders after primary gamma knife radiosurgery for pituitary adenomas: A systematic review and meta-analysis","volume":"25","author":"Palmisciano","year":"2022","journal-title":"Pituitary"},{"key":"B73","doi-asserted-by":"publisher","first-page":"100806","DOI":"10.1016\/j.adro.2021.100806","article-title":"Dosimetric comparison of proton versus photon radiosurgery for treatment of pituitary adenoma","volume":"6","author":"Sud","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.06.068","article-title":"Outcomes of proton therapy for patients with functional pituitary adenomas","volume":"90","author":"Wattson","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.06.2446","article-title":"Consensus report from the Stockholm pediatric proton therapy conference","volume":"96","author":"Indelicato","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B76","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.radonc.2020.04.052","article-title":"Pencil beam scanning proton therapy for the treatment of craniopharyngioma complicated with radiation-induced cerebral vasculopathies: A dosimetric and linear energy transfer (LET) evaluation","volume":"149","author":"Bolsi","year":"2020","journal-title":"Radiother Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.5843","article-title":"Proton FLASH radiotherapy for the treatment of symptomatic bone metastases: The FAST-01 nonrandomized trial","volume":"9","author":"Mascia","year":"2022","journal-title":"JAMA Oncol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.02.020","article-title":"Neuroprotective effects of ultra-high dose rate FLASH Bragg peak proton irradiation","volume":"113","author":"Dokic","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/life11121412","article-title":"Radiotherapy in current neuro-oncology: There is still much to reveal","volume":"11","author":"Ferini","year":"2021","journal-title":"Life (Basel)"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1123082\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T06:00:24Z","timestamp":1683266424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1123082\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":79,"alternative-id":["10.3389\/fonc.2023.1123082"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1123082","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]},"article-number":"1123082"}}